Daniel Gallo
Senior Vice President, Medical Affairs and Advocacy
Professional Overview
Daniel Gallo is an experienced pharmaceutical executive with a proven track record in medical affairs and advocacy. As the Senior Vice President of Medical Affairs and Advocacy at Zevra Therapeutics, he leverages his deep industry knowledge and leadership skills to drive strategic initiatives that enhance patient access and outcomes.
Experience Summary
Current Role
In his current role at Zevra Therapeutics, Daniel is responsible for leading the company's medical affairs and advocacy efforts, collaborating closely with cross-functional teams to ensure the successful development and commercialization of innovative therapies. He oversees a team of medical affairs professionals and serves as a key liaison between the company, healthcare providers, and patient advocacy groups, working to enhance disease awareness and foster collaborative partnerships.
Career Progression
Prior to joining Zevra Therapeutics, Daniel held several senior-level positions in the pharmaceutical industry, including Vice President, Head of Medical Affairs at Jaguar Gene Therapy and Vice President, Head of US Medical Affairs at Orphazyme A/S. In these roles, he demonstrated his ability to navigate complex regulatory environments, strengthen medical and scientific communications, and drive successful market access strategies. Earlier in his career, Daniel served as a US Medical Director for Compliment Inhibitors at Sanofi Genzyme and as an MSL Director for Neuroscience/Psychiatry at Syneos Health, further expanding his expertise in medical affairs and advocacy.
Academic Background
Daniel holds a Bachelor of Science degree in Biochemistry from the University of Illinois at Urbana-Champaign, where he graduated with honors. His academic achievements and strong scientific foundation have been instrumental in his professional development and success within the pharmaceutical industry.
Areas of Expertise
- Medical affairs strategy and execution
- Regulatory compliance and medical-legal review
- Stakeholder engagement and advocacy
- Strategic partnership development
- Cross-functional collaboration and team leadership
- Disease awareness and patient-centric initiatives
Professional Impact
Throughout his career, Daniel has made significant contributions to the pharmaceutical industry, driving innovative medical affairs and advocacy programs that have directly impacted patient access and care. He has successfully launched new therapies, fostered collaborative partnerships with healthcare providers and patient advocacy groups, and advocated for improved disease awareness and treatment options.
Conclusion
With his extensive experience, proven leadership skills, and deep industry expertise, Daniel Gallo is poised to continue driving transformative change in the medical affairs and advocacy landscape. As the Senior Vice President of Medical Affairs and Advocacy at Zevra Therapeutics, he is committed to advancing the company's mission and positively impacting the lives of patients worldwide.
